ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 142 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $73,600 | -8.1% | 49,730 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $80,065 | -44.5% | 49,730 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $144,217 | +21.9% | 49,730 | +37.9% | 0.00% | 0.0% |
Q4 2022 | $118,319 | -33.8% | 36,073 | -23.7% | 0.00% | -50.0% |
Q3 2022 | $178,756 | -45.5% | 47,290 | +12.3% | 0.00% | -33.3% |
Q2 2022 | $328,006 | -24.4% | 42,106 | -9.8% | 0.00% | 0.0% |
Q1 2022 | $433,685 | -7.5% | 46,683 | +56.9% | 0.00% | -25.0% |
Q4 2021 | $468,907 | -12.0% | 29,753 | 0.0% | 0.00% | -20.0% |
Q3 2021 | $532,579 | +15.1% | 29,753 | 0.0% | 0.01% | +25.0% |
Q2 2021 | $462,659 | +8.3% | 29,753 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $427,253 | -26.8% | 29,753 | 0.0% | 0.00% | -33.3% |
Q4 2020 | $584,051 | +51.5% | 29,753 | 0.0% | 0.01% | +50.0% |
Q3 2020 | $385,599 | -11.1% | 29,753 | 0.0% | 0.00% | -20.0% |
Q2 2020 | $433,501 | +114.3% | 29,753 | +25.2% | 0.01% | +66.7% |
Q1 2020 | $202,300 | -48.3% | 23,772 | 0.0% | 0.00% | -25.0% |
Q4 2019 | $391,525 | +16.6% | 23,772 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $335,661 | -11.4% | 23,772 | +26.2% | 0.00% | 0.0% |
Q2 2019 | $378,812 | -49.4% | 18,837 | 0.0% | 0.00% | -50.0% |
Q1 2019 | $748,771 | +14.4% | 18,837 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $654,397 | -16.0% | 18,837 | 0.0% | 0.01% | 0.0% |
Q3 2018 | $778,910 | +12.6% | 18,837 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $692,000 | +17.9% | 18,837 | +25.1% | 0.01% | +14.3% |
Q1 2018 | $587,000 | +170.5% | 15,056 | +25.9% | 0.01% | +250.0% |
Q4 2017 | $217,000 | – | 11,963 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARBOR CAPITAL ADVISORS, INC. | 208,827 | $107,086 | 0.02% |